These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16982459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A, Lim LL, Tao M.
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [Abstract] [Full Text] [Related]

  • 4. Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.
    Christodoulou C, Dafni U, Aravantinos G, Koutras A, Samantas E, Karina M, Janinis J, Papakostas P, Skarlos D, Kalofonos HP, Fountzilas G.
    Anticancer Res; 2009 Feb; 29(2):693-702. PubMed ID: 19331224
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 10. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
    Bell D, Grimes D, Gurney H, Dalley D, Blackwell T, Fox R, Jeffery M.
    Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 15. A single institutional experience: is epoetin alpha effective in anemic children with cancer?
    Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K.
    Pediatr Hematol Oncol; 2004 Mar; 21(1):1-8. PubMed ID: 14660300
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
    Rossert J, Gassmann-Mayer C, Frei D, McClellan W.
    Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
    [Abstract] [Full Text] [Related]

  • 17. Optimized pro-active management of anemia by Epoetin alpha in pre-operative chemotherapy for primary breast cancer.
    Warm M, Kates R, Dick M, Thomas A, Mallmann P, Hoopmann M, Harbeck N.
    Oncol Rep; 2009 Mar; 21(3):777-85. PubMed ID: 19212639
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment.
    Choy CK, Spencer AP, Nappi JM.
    Pharmacotherapy; 2007 May; 27(5):707-14. PubMed ID: 17461706
    [Abstract] [Full Text] [Related]

  • 19. Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.
    Iconomou G, Koutras A, Karaivazoglou K, Kalliolias GD, Assimakopoulos K, Argyriou AA, Ifanti A, Kalofonos HP.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):535-41. PubMed ID: 18707621
    [Abstract] [Full Text] [Related]

  • 20. Ascorbic acid use in hyporesponders to Epoetin alfa.
    Gibbs MA.
    Nephrol Nurs J; 2000 Aug; 27(4):413-5. PubMed ID: 11276634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.